Medicine recalls
|
| |
| The United States：PDX Aromatics expands recall of kratom products because of possible health risk |
| |
The US Food and Drug Administration (FDA) announces that PDX Aromatics, DBA Kraken Kratom, Phytoextractum, and Soul Speciosa, is expanding the scope of their 9 Mar 2018 voluntary recall of certain kratom white vein powder and capsule products and red vein powder products because they have the potential to be contaminated with Salmonella. The expanded recall is being initiated in response to additional positive findings of Salmonella associated with Aromatics’ products following the FDA initial investigation. The expanded recall includes white vein and red vein powder and capsule products shipped between 18 Jan 2018 and 8 Mar 2018. For details of the expanded recalled products, please refer to the website of FDA.
PDX Aromatics has identified a supplier in their supply chain as the source of Salmonella. The company has removed that supplier from their supply chain and all associated products from their facility.
Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm601491.htm
In Hong Kong, the above products are not registered pharmaceutical products. There is also no registered pharmaceutical product containing kratom. Related news was previously issued by FDA, and was posted on the Drug Office website on 12 Mar 2018.
Ends/Monday, Mar 19, 2018
Issued at HKT 15:00
|
| |
|
